Skip to content

Repligen

US · RGEN #1445 by market cap Listed 1970
163.81 -6.48 -3.81%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    CCORF Maintains Repligen(RGEN.US) With Hold Rating, Maintains Target Price $180
    Market Newswire · 2026/10/28
  • Company notice
    CelcomDigi: Change in Boardroom - MR JØRGEN CHRISTIAN ARENTZ ROSTRUP
    Bursa Malaysia · 2022/11/30
  • Rating change
    A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $180 to $235
    Market Newswire · 2026/10/29
  • Rating change
    RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $200
    Market Newswire · 2026/10/28
  • Rating change
    Wells Fargo Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $185
    Market Newswire · 2026/7/30
  • Barclays Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $225
    Market Newswire · 2026/10/7
  • Company notice
    Nike | 8-K: Jørgen Vig Knudstorp Nominated to Join NIKE Board of Directors
    SEC · 2025/6/26
  • Rating change
    CCORF Maintains Repligen(RGEN.US) With Hold Rating, Raises Target Price to $180
    Market Newswire · 2026/10/19
  • Rating change
    Wells Fargo Initiates Repligen(RGEN.US) With Buy Rating, Announces Target Price $185
    Market Newswire · 2026/8/17
  • Rating change
    J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $175
    Market Newswire · 2026/7/29
  • Rating change
    Repligen (RGEN) Receives a Buy From J.P. Morgan
    TipRanks · 2026/10/17
  • Barclays Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $225
    Market Newswire · 2026/10/28
  • Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207
    Market Newswire · 2026/11/11
  • Company notice
    CDB: Change in Boardroom - MR JØRGEN CHRISTIAN ARENTZ ROSTRUP
    Bursa Malaysia · 2023/9/29
  • RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $200
    Market Newswire · 2026/11/2
  • Rating change
    Stifel Maintains Repligen(RGEN.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    UBS Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $225
    Market Newswire · 2026/9/29
  • J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $205
    Market Newswire · 2026/10/30
  • Rating change
    J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $200
    Market Newswire · 2026/10/17
  • Rating change
    CCORF Maintains Repligen(RGEN.US) With Hold Rating, Maintains Target Price $145
    Market Newswire · 2026/7/29
  • Rating change
    Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207
    Market Newswire · 2026/7/30
  • Rating change
    A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $175 to $200
    Market Newswire · 2026/7/29
  • Rating change
    Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160
    Market Newswire · 2026/7/6
  • Rating change
    RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $160
    Market Newswire · 2026/7/24
  • Rating change
    William Blair Maintains Repligen(RGEN.US) With Buy Rating
    Market Newswire · 2026/7/22

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Repligen discussion 0 comments

Add a comment